122 related articles for article (PubMed ID: 16614063)
1. Dynamic responses of the glutathione system to acute oxidative stress in dystrophic mouse (mdx) muscles.
Dudley RW; Khairallah M; Mohammed S; Lands L; Des Rosiers C; Petrof BJ
Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R704-10. PubMed ID: 16614063
[TBL] [Abstract][Full Text] [Related]
2. Increased oxidative stress in dystrophin deficient (mdx) mice masticatory muscles.
Spassov A; Gredes T; Gedrange T; Pavlovic D; Lupp A; Kunert-Keil C
Exp Toxicol Pathol; 2011 Sep; 63(6):549-52. PubMed ID: 20471229
[TBL] [Abstract][Full Text] [Related]
3. Low-Level Laser Therapy (LLLT) in Dystrophin-Deficient Muscle Cells: Effects on Regeneration Capacity, Inflammation Response and Oxidative Stress.
Macedo AB; Moraes LH; Mizobuti DS; Fogaça AR; Moraes Fdos S; Hermes Tde A; Pertille A; Minatel E
PLoS One; 2015; 10(6):e0128567. PubMed ID: 26083527
[TBL] [Abstract][Full Text] [Related]
4. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice.
Mok E; Constantin B; Favreau F; Neveux N; Magaud C; Delwail A; Hankard R
Pediatr Res; 2008 Mar; 63(3):268-73. PubMed ID: 18287965
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy.
Ragusa RJ; Chow CK; Porter JD
Neuromuscul Disord; 1997 Sep; 7(6-7):379-86. PubMed ID: 9327402
[TBL] [Abstract][Full Text] [Related]
7. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice.
Nakae Y; Stoward PJ; Kashiyama T; Shono M; Akagi A; Matsuzaki T; Nonaka I
J Mol Histol; 2004 Jun; 35(5):489-99. PubMed ID: 15571326
[TBL] [Abstract][Full Text] [Related]
8. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
10. GSH system in relation to redox state in dystrophic skin fibroblasts.
Degl'Innocenti D; Rosati F; Iantomasi T; Vincenzini MT; Ramponi G
Biochimie; 1999 Nov; 81(11):1025-9. PubMed ID: 10575357
[TBL] [Abstract][Full Text] [Related]
11. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
12. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
Terrill JR; Boyatzis A; Grounds MD; Arthur PG
Int J Biochem Cell Biol; 2013 Sep; 45(9):2097-108. PubMed ID: 23892094
[TBL] [Abstract][Full Text] [Related]
14. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
15. Protection of dystrophic muscle cells using Idebenone correlates with the interplay between calcium, oxidative stress and inflammation.
Valduga AH; Mizobuti DS; Moraes FDSR; Mâncio RD; Moraes LHR; Hermes TA; Macedo AB; Minatel E
Int J Exp Pathol; 2023 Feb; 104(1):4-12. PubMed ID: 36565155
[TBL] [Abstract][Full Text] [Related]
16. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
17. Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses.
Dudley RW; Danialou G; Govindaraju K; Lands L; Eidelman DE; Petrof BJ
Am J Pathol; 2006 Apr; 168(4):1276-87; quiz 1404-5. PubMed ID: 16565501
[TBL] [Abstract][Full Text] [Related]
18. Low intensity training of mdx mice reduces carbonylation and increases expression levels of proteins involved in energy metabolism and muscle contraction.
Hyzewicz J; Tanihata J; Kuraoka M; Ito N; Miyagoe-Suzuki Y; Takeda S
Free Radic Biol Med; 2015 May; 82():122-36. PubMed ID: 25660994
[TBL] [Abstract][Full Text] [Related]
19. Expression rate of myogenic regulatory factors and muscle growth factor after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx) mice.
Botzenhart UU; Gerlach R; Gredes T; Rentzsch I; Gedrange T; Kunert-Keil C
Adv Clin Exp Med; 2019 Jan; 28(1):11-18. PubMed ID: 30085421
[TBL] [Abstract][Full Text] [Related]
20. Activation of aconitase in mouse fast-twitch skeletal muscle during contraction-mediated oxidative stress.
Zhang SJ; Sandström ME; Lanner JT; Thorell A; Westerblad H; Katz A
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C1154-9. PubMed ID: 17615160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
